Skip to main content

CORRECTION article

Front. Pharmacol., 27 February 2020
Sec. Experimental Pharmacology and Drug Discovery
Volume 11 - 2020 | https://doi.org/10.3389/fphar.2020.00201

Corrigendum: An Improved Enzyme-Linked Focus Formation Assay Revealed Baloxavir Acid as a Potential Antiviral Therapeutic Against Hantavirus Infection

This article is a correction to:

  1. An Improved Enzyme-Linked Focus Formation Assay Revealed Baloxavir Acid as a Potential Antiviral Therapeutic Against Hantavirus Infection

    1. Read original article
\nChuantao Ye,&#x;Chuantao Ye1,2†Dan Wang&#x;&#x;Dan Wang3‡†He LiuHe Liu1Hongwei MaHongwei Ma1Yangchao DongYangchao Dong1Min YaoMin Yao1Yuan WangYuan Wang1Hui ZhangHui Zhang1Liang ZhangLiang Zhang1Linfeng ChengLinfeng Cheng1Zhikai XuZhikai Xu1Yingfeng Lei Yingfeng Lei1*Fanglin Zhang Fanglin Zhang1*Wei Ye Wei Ye1*
  • 1Department of Microbiology, School of Preclinical Medicine, Fourth Military Medical University, Xi'an, China
  • 2Department of Infectious Diseases, Tangdu Hospital, Fourth Military Medical University, Xi'an, China
  • 3School of Pharmaceutical Science, Shanxi Medical University, Taiyuan, China

A Corrigendum on
An Improved Enzyme-Linked Focus Formation Assay Revealed Baloxavir Acid as a Potential Antiviral Therapeutic Against Hantavirus Infection

by Ye, C., Wang, D., Liu, H., Ma, H., Dong, Y., Yao, M., et al. (2019). Front. Pharmacol. 10:1203. doi: 10.3389/fphar.2019.01203

An author's name was incorrectly spelled as “Chuangtao Ye”. The correct spelling is “Chuantao Ye”.

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Keywords: viral nucleic acid synthesis inhibitors, hantavirus, FFA, T-705, BXA

Citation: Ye C, Wang D, Liu H, Ma H, Dong Y, Yao M, Wang Y, Zhang H, Zhang L, Cheng L, Xu Z, Lei Y, Zhang F and Ye W (2020) Corrigendum: An Improved Enzyme-Linked Focus Formation Assay Revealed Baloxavir Acid as a Potential Antiviral Therapeutic Against Hantavirus Infection. Front. Pharmacol. 11:201. doi: 10.3389/fphar.2020.00201

Received: 10 February 2020; Accepted: 14 February 2020;
Published: 27 February 2020.

Approved by:

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Copyright © 2020 Ye, Wang, Liu, Ma, Dong, Yao, Wang, Zhang, Zhang, Cheng, Xu, Lei, Zhang and Ye. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Wei Ye, virologyyw@fmmu.edu.cn; Yingfeng Lei, yflei@fmmu.edu.cn; Fanglin Zhang, flzhang@fmmu.edu.cn

†These authors share first authorship

‡Present address: Dan Wang, Second Affiliated Hospital, Xi'an Medical University, Xi'an, China

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.